{
    "2014-04-09": [
        "RT @theflynews: $GILD $ESRX $MRK $ABBV $BMY $ABT Gilead defended by analysts after recent pullback",
        "GS hepC survey data: expect to use this regimen in 30% of their patients if priced on par to GILDâ€™s regimen, 2x higher than consensus $ABBV",
        "Would you like great research on stocks $FE $FITB $ABBV $AAPL Must have"
    ]
}